By inducing hypoxia environment, reducing adhesion molecules and promoting angiogenesis in the bone marrow, MMSA-1 ultimately reduced the interaction between myeloma cells and bone marrow environment, helped myeloma cells and disease progression. Here, ZDHHC9 is linked to plasma cell myeloma.